On 29th May 2020, following Solidarity Call to Action, the COVID-19 Technology Access Pool (C-TAP) was launched. C-TAP is an initiative aimed at making treatments, vaccines, tests, and other health technologies to fight COVID-19 accessible to all. The Medicines Patent Pool (MPP) looks forward to working collaboratively with all stakeholders to contribute to efforts to address the current COVID-19 crisis.

One of the key elements of C-TAP is licensing any potential treatment, diagnostic, vaccine or other health technology to the UN-backed Medicines Patent Pool. MPP’s Board already temporarily expanded its mandate to COVID-19 treatments & technologies on 31st March 2020.

Marking the launch, WHO and Costa Rica co-sponsored a high-level event addressed by the WHO Director General, President of Costa Rica as well as other delegates from countries, the UN, academia, industry and civil society, including MPP’s Executive Director Charles Gore. Watch the event here (Charles’ intervention at 51:50).